Sana Biotechnology (SANA) Change in Account Payables (2020 - 2026)
Sana Biotechnology (SANA) posted Change in Account Payables of $454000.0 for Q1 2026, up 340.21% sequentially from -$189000.0 in Q4 2025, and up 110.75% YoY from $215423.1 in Q1 2025.
Powered by 
Analysis
Sana Biotechnology (SANA) Change in Account Payables (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Change in Account Payables for 7 years, with the latest figure at $454000.0 in Q1 2026.
- Quarterly Change in Account Payables rose 110.75% year-over-year to $454000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 163.54% YoY) and the FY2025 annual result came in at -$3.5 million, down 357.44% from the prior year.
- Change in Account Payables climbed to $454000.0 in Q1 2026 per SANA's latest filing, from -$189000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.3 million in Q4 2024 and troughed at -$4.2 million in Q1 2025.
- A 5-year average of $21823.5 and a median of -$189000.0 in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables soared 270.73% in 2024, then sank 296.99% in 2025.
- Over 5 years, Change in Account Payables stood at -$1.1 million in 2022, then fell by 23.02% to -$1.3 million in 2023, then jumped by 270.73% to $2.3 million in 2024, then plunged by 108.29% to -$189000.0 in 2025, then soared by 340.21% to $454000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $454000.0, -$189000.0, and -$357000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Sana Biotechnology | 1.14 Bn | 1.14 Bn | - | -851,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -851,000.00 |
| Mar 31, 2026 | 454,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Sep 30, 2025 | -357,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | -4.22 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | -507,000.00 |
| Jun 30, 2024 | 667,000.00 |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | -1.34 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 441,000.00 |
| Mar 31, 2023 | -354,000.00 |
| Dec 31, 2022 | -1.09 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | -1.25 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | -1.66 Mn |
| Sep 30, 2021 | 1.77 Mn |